Open AccessHemolytic Dynamics of Weekly Primaquine Antirelapse Therapy Among Cambodians With Acute Plasmodium vivax Malaria With or Without Glucose-6-Phosphate Dehydrogenase Deficiency
Author(s) -
Walter Taylor,
Sim Kheng,
Sinoun Muth,
Pety Tor,
Saorin Kim,
Steven Bjorge,
Narann Topps,
Khem Kosal,
Khon Sothea,
Phum Souy,
Chuor Meng Char,
Chan Vanna,
Po Ly,
Virak Khieu,
Eva Christophel,
Alexandra Kerléguer,
Antonella Pantaleo,
Mavuto Mukaka,
Didier Ménard,
J. Kevin Baird
Publication year - 2019
Publication title -
the journal of infectious diseases (online. university of chicago press)/the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/jiz313
Subject(s) - primaquine , medicine , plasmodium vivax , parasitemia , gastroenterology , malaria , hemoglobin , plasmodium falciparum , glucose 6 phosphate dehydrogenase deficiency , immunology , chloroquine
Hemoglobin (Hb) data are limited in Southeast Asian glucose-6-phosphate dehydrogenase (G6PD) deficient (G6PD-) patients treated weekly with the World Health Organization-recommended primaquine regimen (ie, 0.75 mg/kg/week for 8 weeks [PQ 0.75]).